Global Bio Similars/Subsequent Entry Biologic Market 2020 by Company, Type and Application, Forecast to 2025

Report ID: 50457 | Publish Date: May, 2020 | Pages: 156 | Format : PDF

Market Overview

The global Bio Similars/Subsequent Entry Biologic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Bio Similars/Subsequent Entry Biologic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Bio Similars/Subsequent Entry Biologic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for revenue by Type and Application. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, Bio Similars/Subsequent Entry Biologic market has been segmented into Monoclonal Antibodies, Interferon, Erythropoietin, Insulin, Vaccines, Other, etc.

Breakdown by Application, Bio Similars/Subsequent Entry Biologic has been segmented into Tumor, Diabetes, Cardiovascular, Hemophilia, Other, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global Bio Similars/Subsequent Entry Biologic market presented in the report. This section sheds light on the sales growth of different regional and country-level Bio Similars/Subsequent Entry Biologic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Bio Similars/Subsequent Entry Biologic market.

For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and Bio Similars/Subsequent Entry Biologic Market Share Analysis

Bio Similars/Subsequent Entry Biologic competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Bio Similars/Subsequent Entry Biologic revenue generated, market share, headquarters, SWOT analysis, product launch. For the period 2015-2020, this study provides the Bio Similars/Subsequent Entry Biologic revenue and market share for each player covered in this report.

The major players covered in Bio Similars/Subsequent Entry Biologic are: Sun Pharma, Biogen idec, LG Life Sciences, Synthon Pharmaceuticals, Merck, Teva Pharmaceutical Industries, Pfizer, Hospira, Celltrion Biocon, Genentech (Roche), Mylan, AbbVie, Celltrion, Johnson & Johnson, Dr. Reddy's Laboratories, Samsung Biologics, Biocon, Sanofi-Aventis, Stada Arzneimittel AG, Amgen, Innovent, Novo Nordisk, Gelgen, Biotech, Ganlee, 3sbio, Eli Lilly, Dong Bao, Novartis, etc. Among other players domestic and global, Bio Similars/Subsequent Entry Biologic market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Market segment by players, this report covers

Sun Pharma

Biogen idec

LG Life Sciences

Synthon Pharmaceuticals

Merck

Teva Pharmaceutical Industries

Pfizer

Hospira

Celltrion Biocon

Genentech (Roche)

Mylan

AbbVie

Celltrion

Johnson & Johnson

Dr. Reddy's Laboratories

Samsung Biologics

Biocon

Sanofi-Aventis

Stada Arzneimittel AG

Amgen

Innovent

Novo Nordisk

Gelgen

Biotech

Ganlee

3sbio

Eli Lilly

Dong Bao

Novartis

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

MENA (Saudi Arabia, UAE, Turkey and South Africa)

Market segment by Type, covers:

Monoclonal Antibodies

Interferon

Erythropoietin

Insulin

Vaccines

Other

Market segment by Application, can be divided into

Tumor

Diabetes

Cardiovascular

Hemophilia

Other


Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Product Overview and Scope of Bio Similars/Subsequent Entry Biologic

1.2 Classification of Bio Similars/Subsequent Entry Biologic by Type

1.2.1 Overview: Global Bio Similars/Subsequent Entry Biologic Revenue by Type: 2015 Versus 2019 Versus 2025

1.2.2 Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type in 2019

1.2.3 Monoclonal Antibodies

1.2.4 Interferon

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Other

1.3 Global Bio Similars/Subsequent Entry Biologic Market by Application

1.3.1 Overview: Global Bio Similars/Subsequent Entry Biologic Revenue by Application: 2015 Versus 2019 Versus 2025

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Other

1.4 Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

1.5 Global Bio Similars/Subsequent Entry Biologic Market Size by Regions: 2015 VS 2019 VS 2025

1.6 Global Bio Similars/Subsequent Entry Biologic Market Size by Regions (2015-2020)

1.7 Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Regions (2020-2025)

1.7.1 North America Bio Similars/Subsequent Entry Biologic Status and Prospect (2015-2025)

1.7.2 Europe Bio Similars/Subsequent Entry Biologic Status and Prospect (2015-2025)

1.7.3 Asia Bio Similars/Subsequent Entry Biologic Status and Prospect (2015-2025)

1.7.4 South America Bio Similars/Subsequent Entry Biologic Status and Prospect (2015-2025)

1.7.5 Middle East & Africa Bio Similars/Subsequent Entry Biologic Status and Prospect (2015-2025)

2 Company Profiles

2.1 Sun Pharma

2.1.1 Sun Pharma Details

2.1.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis

2.1.3 Sun Pharma SWOT Analysis

2.1.4 Sun Pharma Product and Services

2.1.5 Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.2 Biogen idec

2.2.1 Biogen idec Details

2.2.2 Biogen idec Major Business and Total Revenue (Financial Highlights) Analysis

2.2.3 Biogen idec SWOT Analysis

2.2.4 Biogen idec Product and Services

2.2.5 Biogen idec Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.3 LG Life Sciences

2.3.1 LG Life Sciences Details

2.3.2 LG Life Sciences Major Business and Total Revenue (Financial Highlights) Analysis

2.3.3 LG Life Sciences SWOT Analysis

2.3.4 LG Life Sciences Product and Services

2.3.5 LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.4 Synthon Pharmaceuticals

2.4.1 Synthon Pharmaceuticals Details

2.4.2 Synthon Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis

2.4.3 Synthon Pharmaceuticals SWOT Analysis

2.4.4 Synthon Pharmaceuticals Product and Services

2.4.5 Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.5 Merck

2.5.1 Merck Details

2.5.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis

2.5.3 Merck SWOT Analysis

2.5.4 Merck Product and Services

2.5.5 Merck Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.6 Teva Pharmaceutical Industries

2.6.1 Teva Pharmaceutical Industries Details

2.6.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis

2.6.3 Teva Pharmaceutical Industries SWOT Analysis

2.6.4 Teva Pharmaceutical Industries Product and Services

2.6.5 Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.7 Pfizer

2.7.1 Pfizer Details

2.7.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis

2.7.3 Pfizer SWOT Analysis

2.7.4 Pfizer Product and Services

2.7.5 Pfizer Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.8 Hospira

2.8.1 Hospira Details

2.8.2 Hospira Major Business and Total Revenue (Financial Highlights) Analysis

2.8.3 Hospira SWOT Analysis

2.8.4 Hospira Product and Services

2.8.5 Hospira Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.9 Celltrion Biocon

2.9.1 Celltrion Biocon Details

2.9.2 Celltrion Biocon Major Business and Total Revenue (Financial Highlights) Analysis

2.9.3 Celltrion Biocon SWOT Analysis

2.9.4 Celltrion Biocon Product and Services

2.9.5 Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.10 Genentech (Roche)

2.10.1 Genentech (Roche) Details

2.10.2 Genentech (Roche) Major Business and Total Revenue (Financial Highlights) Analysis

2.10.3 Genentech (Roche) SWOT Analysis

2.10.4 Genentech (Roche) Product and Services

2.10.5 Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.11 Mylan

2.11.1 Mylan Details

2.11.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis

2.11.3 Mylan SWOT Analysis

2.11.4 Mylan Product and Services

2.11.5 Mylan Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.12 AbbVie

2.12.1 AbbVie Details

2.12.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis

2.12.3 AbbVie SWOT Analysis

2.12.4 AbbVie Product and Services

2.12.5 AbbVie Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.13 Celltrion

2.13.1 Celltrion Details

2.13.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis

2.13.3 Celltrion SWOT Analysis

2.13.4 Celltrion Product and Services

2.13.5 Celltrion Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.14 Johnson & Johnson

2.14.1 Johnson & Johnson Details

2.14.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis

2.14.3 Johnson & Johnson SWOT Analysis

2.14.4 Johnson & Johnson Product and Services

2.14.5 Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.15 Dr. Reddy's Laboratories

2.15.1 Dr. Reddy's Laboratories Details

2.15.2 Dr. Reddy's Laboratories Major Business and Total Revenue (Financial Highlights) Analysis

2.15.3 Dr. Reddy's Laboratories SWOT Analysis

2.15.4 Dr. Reddy's Laboratories Product and Services

2.15.5 Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.16 Samsung Biologics

2.16.1 Samsung Biologics Details

2.16.2 Samsung Biologics Major Business and Total Revenue (Financial Highlights) Analysis

2.16.3 Samsung Biologics SWOT Analysis

2.16.4 Samsung Biologics Product and Services

2.16.5 Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.17 Biocon

2.17.1 Biocon Details

2.17.2 Biocon Major Business and Total Revenue (Financial Highlights) Analysis

2.17.3 Biocon SWOT Analysis

2.17.4 Biocon Product and Services

2.17.5 Biocon Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.18 Sanofi-Aventis

2.18.1 Sanofi-Aventis Details

2.18.2 Sanofi-Aventis Major Business and Total Revenue (Financial Highlights) Analysis

2.18.3 Sanofi-Aventis SWOT Analysis

2.18.4 Sanofi-Aventis Product and Services

2.18.3 Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.19 Stada Arzneimittel AG

2.19.1 Stada Arzneimittel AG Details

2.19.2 Stada Arzneimittel AG Major Business and Total Revenue (Financial Highlights) Analysis

2.19.3 Stada Arzneimittel AG SWOT Analysis

2.19.4 Stada Arzneimittel AG Product and Services

2.19.5 Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.20 Amgen

2.20.1 Amgen Details

2.20.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis

2.20.3 Amgen SWOT Analysis

2.20.4 Amgen Product and Services

2.20.5 Amgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.21 Innovent

2.21.1 Innovent Details

2.21.2 Innovent Major Business and Total Revenue (Financial Highlights) Analysis

2.21.3 Innovent SWOT Analysis

2.21.4 Innovent Product and Services

2.21.5 Innovent Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.22 Novo Nordisk

2.22.1 Novo Nordisk Details

2.22.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis

2.22.3 Novo Nordisk SWOT Analysis

2.22.4 Novo Nordisk Product and Services

2.22.5 Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.23 Gelgen

2.23.1 Gelgen Details

2.23.2 Gelgen Major Business and Total Revenue (Financial Highlights) Analysis

2.23.3 Gelgen SWOT Analysis

2.23.4 Gelgen Product and Services

2.23.5 Gelgen Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.24 Biotech

2.24.1 Biotech Details

2.24.2 Biotech Major Business and Total Revenue (Financial Highlights) Analysis

2.24.3 Biotech SWOT Analysis

2.24.4 Biotech Product and Services

2.24.5 Biotech Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.25 Ganlee

2.25.1 Ganlee Details

2.25.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis

2.25.3 Ganlee SWOT Analysis

2.25.4 Ganlee Product and Services

2.25.5 Ganlee Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.26 3sbio

2.26.1 3sbio Details

2.26.2 3sbio Major Business and Total Revenue (Financial Highlights) Analysis

2.26.3 3sbio SWOT Analysis

2.26.4 3sbio Product and Services

2.26.5 3sbio Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.27 Eli Lilly

2.27.1 Eli Lilly Details

2.27.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis

2.27.3 Eli Lilly SWOT Analysis

2.27.4 Eli Lilly Product and Services

2.27.5 Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.28 Dong Bao

2.28.1 Dong Bao Details

2.28.2 Dong Bao Major Business and Total Revenue (Financial Highlights) Analysis

2.28.3 Dong Bao SWOT Analysis

2.28.4 Dong Bao Product and Services

2.28.5 Dong Bao Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

2.29 Novartis

2.29.1 Novartis Details

2.29.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis

2.29.3 Novartis SWOT Analysis

2.29.4 Novartis Product and Services

2.29.5 Novartis Bio Similars/Subsequent Entry Biologic Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

3.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Players (2015-2020)

3.2 United States Bio Similars/Subsequent Entry Biologic Market Size by Players (2015-2020)

3.3 Market Concentration Rate

3.3.1 Top 5 Bio Similars/Subsequent Entry Biologic Players Market Share

3.3.2 Top 10 Bio Similars/Subsequent Entry Biologic Players Market Share

4 North America Market Size and Forecast by Countries

4.1 North America Bio Similars/Subsequent Entry Biologic Market Size by Countries (2015-2020)

4.2 North America Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Countries (2015-2026)

4.3 United States Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

4.4 Canada Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

4.5 Mexico Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

5 Europe Market Size and Forecast by Countries

5.1 Europe Bio Similars/Subsequent Entry Biologic Market Size by Countries (2015-2020)

5.2 Europe Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Countries (2015-2026)

5.3 Germany Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

5.4 France Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

5.5 UK Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

5.6 Russia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

5.7 Italy Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

6 Asia-Pacific Market Size and Forecast by Countries

6.1 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size by Regions (2015-2020)

6.2 Asia-Pacific Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Regions (2015-2026)

6.3 China Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

6.4 Japan Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

6.5 Korea Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

6.6 India Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

6.7 Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

7 South America Market Size and Forecast by Countries

7.1 South America Bio Similars/Subsequent Entry Biologic Market Size by Countries (2015-2020)

7.2 South America Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Countries (2015-2026)

7.3 Brazil Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

7.4 Argentina Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

8 Middle East & Africa Market Size and Forecast by Countries

8.1 Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue by Regions (2015-2020)

8.2 Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Countries (2015-2026)

8.3 Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

8.4 UAE Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

8.5 Egypt Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

8.6 South Africa Bio Similars/Subsequent Entry Biologic Market Size and Forecast (2015-2025)

9 Market Size Segment by Type

9.1 Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Type (2015-2025)

9.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)

9.1.2 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Type (2020-2025)

9.2 United States Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Type (2015-2025)

9.2.1 United States Bio Similars/Subsequent Entry Biologic Market Size by Type (2015-2020)

9.2.2 United States Bio Similars/Subsequent Entry Biologic Market Size Forecast by Type (2020-2025)

10 Market Size Segment by Application

10.1 Global Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Application (2015-2025)

10.1.1 Global Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)

10.1.2 Global Bio Similars/Subsequent Entry Biologic Market Size Forecast by Application (2020-2025)

10.2 United States Bio Similars/Subsequent Entry Biologic Market Size and Forecast by Application (2015-2025)

10.2.1 United States Bio Similars/Subsequent Entry Biologic Market Size by Application (2015-2020)

10.2.2 United States Bio Similars/Subsequent Entry Biologic Market Size Forecast by Application (2020-2025)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Data Source

12.3 Disclaimer

12.4 About US

List of Tables

Table 1. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Type: 2015 Versus 2019 Versus 2025

Table 2. Breakdown of Bio Similars/Subsequent Entry Biologic by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Application: 2015 Versus 2019 Versus 2025

Table 4. Global Market Bio Similars/Subsequent Entry Biologic Market Size (USD Million) Comparison by Regions (2020-2025)

Table 5. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Regions (2015-2020)

Table 6. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Regions (2015-2020)

Table 7. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Regions (2020-2025)

Table 8. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2020-2025)

Table 9. Sun Pharma Corporate Information, Location and Competitors

Table 10. Sun Pharma Major Business

Table 11. Sun Pharma Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 12. Sun Pharma SWOT Analysis

Table 13. Sun Pharma Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 14. Sun Pharma Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 15. Biogen idec Corporate Information, Location and Competitors

Table 16. Biogen idec Major Business

Table 17. Biogen idec Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2018-2019)

Table 18. Biogen idec SWOT Analysis

Table 19. Biogen idec Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 20. Biogen idec Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 21. LG Life Sciences Corporate Information, Location and Competitors

Table 22. LG Life Sciences Major Business

Table 23. LG Life Sciences Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 24. LG Life Sciences SWOT Analysis

Table 25. LG Life Sciences Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 26. LG Life Sciences Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 27. Synthon Pharmaceuticals Corporate Information, Location and Competitors

Table 28. Synthon Pharmaceuticals Major Business

Table 29. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 30. Synthon Pharmaceuticals SWOT Analysis

Table 31. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 32. Synthon Pharmaceuticals Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 33. Merck Corporate Information, Location and Competitors

Table 34. Merck Major Business

Table 35. Merck Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 36. Merck SWOT Analysis

Table 37. Merck Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 38. Merck Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 39. Teva Pharmaceutical Industries Corporate Information, Location and Competitors

Table 40. Teva Pharmaceutical Industries Major Business

Table 41. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 42. Teva Pharmaceutical Industries SWOT Analysis

Table 43. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 44. Teva Pharmaceutical Industries Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 45. Pfizer Corporate Information, Location and Competitors

Table 46. Pfizer Major Business

Table 47. Pfizer Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 48. Pfizer SWOT Analysis

Table 49. Pfizer Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 50. Pfizer Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 51. Hospira Corporate Information, Location and Competitors

Table 52. Hospira Major Business

Table 53. Hospira Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 54. Hospira SWOT Analysis

Table 55. Hospira Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 56. Hospira Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 57. Celltrion Biocon Corporate Information, Location and Competitors

Table 58. Celltrion Biocon Major Business

Table 59. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 60. Celltrion Biocon SWOT Analysis

Table 61. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 62. Celltrion Biocon Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 63. Genentech (Roche) Corporate Information, Location and Competitors

Table 64. Genentech (Roche) Major Business

Table 65. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 66. Genentech (Roche) SWOT Analysis

Table 67. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 68. Genentech (Roche) Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 69. Mylan Corporate Information, Location and Competitors

Table 70. Mylan Major Business

Table 71. Mylan Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 72. Mylan SWOT Analysis

Table 73. Mylan Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 74. Mylan Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 75. AbbVie Corporate Information, Location and Competitors

Table 76. AbbVie Major Business

Table 77. AbbVie Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 78. AbbVie SWOT Analysis

Table 79. AbbVie Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 80. AbbVie Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 81. Celltrion Corporate Information, Location and Competitors

Table 82. Celltrion Major Business

Table 83. Celltrion Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 84. Celltrion SWOT Analysis

Table 85. Celltrion Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 86. Celltrion Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 87. Johnson & Johnson Corporate Information, Location and Competitors

Table 88. Johnson & Johnson Major Business

Table 89. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 90. Johnson & Johnson SWOT Analysis

Table 91. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 92. Johnson & Johnson Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 93. Dr. Reddy's Laboratories Corporate Information, Location and Competitors

Table 94. Dr. Reddy's Laboratories Major Business

Table 95. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 96. Dr. Reddy's Laboratories SWOT Analysis

Table 97. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 98. Dr. Reddy's Laboratories Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 99. Samsung Biologics Corporate Information, Location and Competitors

Table 100. Samsung Biologics Major Business

Table 101. Samsung Biologics Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 102. Samsung Biologics SWOT Analysis

Table 103. Samsung Biologics Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 104. Samsung Biologics Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 105. Biocon Corporate Information, Location and Competitors

Table 106. Biocon Major Business

Table 107. Biocon Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 108. Biocon SWOT Analysis

Table 109. Biocon Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 110. Biocon Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 111. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Type and Application

Table 112. Sanofi-Aventis Major Business

Table 113. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 114. Sanofi-Aventis SWOT Analysis

Table 115. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 116. Sanofi-Aventis Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 117. Stada Arzneimittel AG Corporate Information, Location and Competitors

Table 118. Stada Arzneimittel AG Major Business

Table 119. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 120. Stada Arzneimittel AG SWOT Analysis

Table 121. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 122. Stada Arzneimittel AG Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 123. Amgen Corporate Information, Location and Competitors

Table 124. Amgen Major Business

Table 125. Amgen Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 126. Amgen SWOT Analysis

Table 127. Amgen Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 128. Amgen Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 129. Innovent Corporate Information, Location and Competitors

Table 130. Innovent Major Business

Table 131. Innovent Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 132. Innovent SWOT Analysis

Table 133. Innovent Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 134. Innovent Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 135. Novo Nordisk Corporate Information, Location and Competitors

Table 136. Novo Nordisk Major Business

Table 137. Novo Nordisk Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 138. Novo Nordisk SWOT Analysis

Table 139. Novo Nordisk Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 140. Novo Nordisk Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 141. Gelgen Corporate Information, Location and Competitors

Table 142. Gelgen Major Business

Table 143. Gelgen Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 144. Gelgen SWOT Analysis

Table 145. Gelgen Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 146. Gelgen Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 147. Biotech Corporate Information, Location and Competitors

Table 148. Biotech Major Business

Table 149. Biotech Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 150. Biotech SWOT Analysis

Table 151. Biotech Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 152. Biotech Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 153. Ganlee Corporate Information, Location and Competitors

Table 154. Ganlee Major Business

Table 155. Ganlee Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 156. Ganlee SWOT Analysis

Table 157. Ganlee Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 158. Ganlee Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 159. 3sbio Corporate Information, Location and Competitors

Table 160. 3sbio Major Business

Table 161. 3sbio Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 162. 3sbio SWOT Analysis

Table 163. 3sbio Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 164. 3sbio Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 165. Eli Lilly Corporate Information, Location and Competitors

Table 166. Eli Lilly Major Business

Table 167. Eli Lilly Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 168. Eli Lilly SWOT Analysis

Table 169. Eli Lilly Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 170. Eli Lilly Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 171. Dong Bao Corporate Information, Location and Competitors

Table 172. Dong Bao Major Business

Table 173. Dong Bao Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 174. Dong Bao SWOT Analysis

Table 175. Dong Bao Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 176. Dong Bao Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 177. Novartis Corporate Information, Location and Competitors

Table 178. Novartis Major Business

Table 179. Novartis Bio Similars/Subsequent Entry Biologic Total Revenue (USD Million) (2017-2018)

Table 180. Novartis SWOT Analysis

Table 181. Novartis Bio Similars/Subsequent Entry Biologic Product and Solutions

Table 182. Novartis Bio Similars/Subsequent Entry Biologic Revenue (USD Million), Gross Margin and Market Share (2018-2019)

Table 183. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Players (2015-2020)

Table 184. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players (2015-2020)

Table 185. Key Players Bio Similars/Subsequent Entry Biologic Revenue (USD Million) in United States (2015-2020)

Table 186. Key Players Bio Similars/Subsequent Entry Biologic Revenue Share in United States (2015-2020)

Table 187. North America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2015-2020)

Table 188. North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2015-2020)

Table 189. North America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2020-2026)

Table 190. North America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2020-2026)

Table 191. Europe Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2015-2020)

Table 192. Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2015-2020)

Table 193. Europe Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2020-2026)

Table 194. Europe Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2020-2026)

Table 195. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2015-2020)

Table 196. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2015-2020)

Table 197. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2020-2026)

Table 198. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2020-2026)

Table 199. South America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2015-2020)

Table 200. South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2015-2020)

Table 201. South America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2020-2026)

Table 202. South America Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2020-2026)

Table 203. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2015-2020)

Table 204. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2015-2020)

Table 205. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Countries (2020-2026)

Table 206. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue Market Share by Countries (2020-2026)

Table 207. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Type (2015-2020)

Table 208. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2015-2020)

Table 209. Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2020-2025)

Table 210. Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2020-2025)

Table 211. United States Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Type (2015-2020)

Table 212. United States Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2015-2020)

Table 213. United States Bio Similars/Subsequent Entry Biologic Revenue Forecast by Type (2020-2025)

Table 214. United States Bio Similars/Subsequent Entry Biologic Market Share Forecast by Type (2020-2025)

Table 215. Global Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Application (2015-2020)

Table 216. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2015-2020)

Table 217. Global Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2020-2025)

Table 218. Global Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2020-2025)

Table 219. United States Bio Similars/Subsequent Entry Biologic Revenue (USD Million) by Application (2015-2020)

Table 220. United States Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2015-2020)

Table 221. United States Bio Similars/Subsequent Entry Biologic Revenue Forecast by Application (2020-2025)

Table 222. United States Bio Similars/Subsequent Entry Biologic Market Share Forecast by Application (2020-2025)

List of Figures

Figure 1. Bio Similars/Subsequent Entry Biologic Picture

Figure 2. Global Bio Similars/Subsequent Entry Biologic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Type in 2019

Figure 4. Monoclonal Antibodies Picture

Figure 5. Interferon Picture

Figure 6. Erythropoietin Picture

Figure 7. Insulin Picture

Figure 8. Vaccines Picture

Figure 9. Other Picture

Figure 10. Bio Similars/Subsequent Entry Biologic Revenue Market Share by Application in 2019

Figure 11. Tumor Picture

Figure 12. Diabetes Picture

Figure 13. Cardiovascular Picture

Figure 14. Hemophilia Picture

Figure 15. Other Picture

Figure 16. Global Bio Similars/Subsequent Entry Biologic Revenue and Growth Rate (2015-2025) (USD Million)

Figure 17. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Regions (2015-2025)

Figure 18. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Regions in 2019

Figure 19. Global Bio Similars/Subsequent Entry Biologic Revenue Market Share by Regions (2020-2025)

Figure 20. North America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2015-2025)

Figure 21. Europe Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2015-2025)

Figure 22. Asia-Pacific Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2015-2025)

Figure 23. South America Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2015-2025)

Figure 24. Middle East & Africa Bio Similars/Subsequent Entry Biologic Revenue (USD Million) and Growth Rate (2015-2025)

Figure 25. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Players in 2019

Figure 26. Global Top 5 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in 2019

Figure 27. Top 10 Players Bio Similars/Subsequent Entry Biologic Revenue Market Share in Global Market in 2019

Figure 28. Global Bio Similars/Subsequent Entry Biologic Market Size (USD Million) by Type (2015-2025)

Figure 29. Global Bio Similars/Subsequent Entry Biologic Market Size Share by Application (2015-2025)

Figure 30. North America Bio Similars/Subsequent Entry Biologic Market Size Share by Countries (2015-2025)

Figure 31. North America Bio Similars/Subsequent Entry Biologic Market Size Share by Countries in 2019

Figure 32. United States Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 33. Canada Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 34. Mexico Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 35. Europe Bio Similars/Subsequent Entry Biologic Market Size Share by Countries (2015-2025)

Figure 36. Europe Bio Similars/Subsequent Entry Biologic Market Size Share by Countries in 2019

Figure 37. Germany Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 38. France Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 39. Russia Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 40. Italy Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 41. Spain Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 42. UK Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 43. Asia Bio Similars/Subsequent Entry Biologic Market Size Share by Countries (2015-2025)

Figure 44. Asia Bio Similars/Subsequent Entry Biologic Market Size Share by Countries in 2019

Figure 45. China Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 46. Japan Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 47. Korea Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 48. India Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 49. Southeast Asia Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 50. South America Bio Similars/Subsequent Entry Biologic Market Size Share by Countries (2015-2025)

Figure 51. South America Bio Similars/Subsequent Entry Biologic Market Size Share by Countries in 2019

Figure 52. Brazil Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 53. Argentina Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 54. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Share by Countries (2015-2025)

Figure 55. Middle East & Africa Bio Similars/Subsequent Entry Biologic Market Size Share by Countries in 2019

Figure 56. Saudi Arabia Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 57. UAE Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 58. Egypt Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 59. South Africa Bio Similars/Subsequent Entry Biologic Market Size (USD Million) and Forecast (2015-2025)

Figure 60. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2015-2020)

Figure 61. United States Bio Similars/Subsequent Entry Biologic Revenue Share by Type (2015-2020)

Figure 62. Global Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2015-2020)

Figure 63. United States Bio Similars/Subsequent Entry Biologic Revenue Share by Application (2015-2020)

Our Clients